Key result
Prior benznidazole treatment in women with Chagas disease resulted in zero observed cases of congenital transmission to their newborns.
Why the study?
Does benznidazole treatment prevent congenital transmission of Chagas disease in women with Chagas disease?
Does benznidazole treatment prevent congenital transmission of Chagas disease in women with Chagas disease?
Treatment of women with Chagas disease with benznidazole prior to pregnancy may prevent congenital transmission to their infants.
Answers are grounded in this paper and cite their sources.
Supports preconception benznidazole to avert congenital Chagas; observational data leaves open causal efficacy pending RCTs.
It is currently unknown whether treatment of Chagas disease decreases the risk of congenital transmission from previously treated mothers to their infants. In a cohort of women with Chagas disease previously treated with benznidazole, no congenital transmission of the disease was observed in their newborns. This finding provides support for the treatment of Chagas disease as early as possible.
No takes yet. Share an insight, caveat, or question.
Moscatelli et al. (2015) studied this question. Prior benznidazole treatment in women with Chagas disease resulted in zero observed cases of congenital transmission to their newborns.
Synapse has enriched 10 related papers. Consider them for comparative context: